Tag: AYTU

Blue Horseshoe Stocks: ENPH Review & More

Aytu BioScience, Inc. AYTU

We’ve done our best this week in reminding readers that our interest in AYTU was not a drill. Beginning from our initial alert in last Wednesday’s premarket report, the stock was exhibiting all the signs of a recovery play.

Yesterday we reiterated our interest for the second time this week, mentioning how the stock had already come a considerable distance from our observed  low of .4118, and that it had picked up momentum on Monday, and that more gains could be in store.

We were right on the money as the stock extended its recent gains yesterday running to a new high of .76, which represents a five day swing of 85%

Enphase Energy, Inc. ENPH

Recently, we have had quite a few plays we’ve signaled within the past couple of months, exhibit really convincing, sustained uptrends, and ENPH is another one to put in that category.

While our most recent mention of the stock came on March 19th, in the midst of the current run as a reminder, our initial call came on February 28th.  On that day, the stock saw a low of 3.07 and hasn’t looked back since.

Yesterday, ENPH surged to a new high of 5.58, marking a respectable one month run of 82% during which time volume has also been greatly increased.


Fresh Options Ideas – Both of the following are looking good today with untraded-upon earnings beats, so we’ve got a pair of fresh ideas to share this morning:

Lululemon Athletica Inc. LULU Weekly $83-85 Calls
Blackberry Ltd. BB Weekly $12.50 & $13 Calls

Extended Watchlist:
TOPS, ANW, IDXG, LHO, MARA

Blue Horseshoe Stocks: AYTU Update & More

Aytu BioScience, Inc. AYTU Yesterday morning, we were just discussing AYTU and the modest progress the stock had made since we flagged it as a bottom play in Wednesday’s premarket report. Not only had it displayed a cherry bottom setup, but we noted a string of insider buysat the time as well.Following that report, we would witness a low of .4118, and over the course of the ensuing four trading days, the stock has made a noteworthy move and continues to exhibit signs that more gains could be in store.

Yesterday it reached .61, which represents a run of 48% in under a week. It did so on record volume, so we’re definitely eager to see where the momentum could carry this play that was already on its way back up.

InspireMD, Inc. NSPR

NSPR has been in real trouble in 2018, losing ground at seemingly every turn and unable to get out of its own way. However, through a combination of a South American breakthrough announcement for two of the companies drugs, and being just plain oversold, we’re seeing a marginal premarket gap-up and will want to observe for a more sustained rebound.

The news was pertaining to NSPR receiving regulatory approval from the goverment of Peru for its CGuard™ Embolic Prevention System (EPS) and MGuard Prime™ products. Peru has a population of more than 30 million people. (>>View PR)

Extended Watchlist:
ARWR, GLOW, MDGS, MBRX, SEE, WBAI, LIQT, PIXY,

Blue Horseshoe Stocks: HOME Recap & More

At Home Group, Inc. HOME 

On Friday morning, we closed out our premarket report with a fresh options trading idea for the HOME options chain, with the HOME 04/20 $30 Calls.

The idea paid instant dividends for our readers and ourselves as those calls traded in a very solid range from 1.20-3.75 on the day, giving us the chance at intraday gains of up to 213% There’s obviously plenty of time to continue tracking this play, but as it is, we’re extrmely pleased with its single session performance on Friday, which registered as the sixth biggest gainer on the NASDAQ.


Aytu BioScience, Inc. AYTU

Another target we selected last week for a bottom-watch play after noticing the chart setup and a string of insider buys, was AYTU. While it didn’t exactly blast off yet, we wanted to go over the move it did make, and reiterate our interest in tracking this play as we kick off this short trading week.

Subsequent to our alert, the stock traded in a range from .4118 to .51, a modest 24% rise, and still has tons of room to run. In fact, the company will need to promptly reach and maintain a 1.00 PPS or risk having NASDAQ forcibly de-list its stock.

Extended Watchlist:
AVID, DBX, GERN, JAGX, SRNE, VII, VKTX